BIO-TECHNE Corp — Director's Dealing 2018

Oct 29, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2018-10-25

Reporting Person: STEER RANDOLPH C (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-10-25	Common Stock	A	514.00	$0.00	Acquired	4226.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-25	Stock Option (right to buy)	$179.84	A	1898.00	Acquired	2028-10-25	Common Stock (1898.00)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$91.78	2024-10-30	Common Stock (4000.00)	4000.00	Direct
Stock Option (right to buy)	$87.39	2023-10-30	Common Stock (4000.00)	4000.00	Direct
Stock Option (right to buy)	$87.34	2025-10-28	Common Stock (4260.00)	4260.00	Direct
Stock Option (right to buy)	$70.35	2021-10-26	Common Stock (5000.00)	5000.00	Direct
Stock Option (right to buy)	$66.90	2022-10-24	Common Stock (5000.00)	5000.00	Direct
Stock Options (Right to buy)	$125.05	2027-10-26	Common Stock (3125.00)	3125.00	Direct
Stock Options (Right to buy)	$101.19	2026-10-26	Common Stock (3985.00)	3985.00	Direct

Footnotes

F1: This option vests on the earlier of the one year anniversary of the grant date (10/25/2019) or the date of Bio-Techne 2019 Annual Meeting of Shareholders.